UsAgainstAlzheimer’s Launches Online Biomarkers Repository to Track Alzheimer’s Research

In an important step to advance Alzheimer’s research, UsAgainstAlzheimer’s today announced the creation of a new online Biomarkers Repository to track research into Alzheimer’s biomarkers and diagnostics. The constantly-evolving Biomarkers Repository will help policymakers, healthcare system leaders and scientific community better understand and support personalized medicine.

The prescription for an effective treatment or cure for Alzheimer’s: More research and cautious optimism

It’s been an exciting few weeks in the Alzheimer’s world – a world that hasn’t seen a new drug in 15 years. All of the activity has raised a lot of questions around the world’s progress toward a cure.

It’s time to pick up the pace on Alzheimer’s prevention

Milken Institute report urges our nation to double down on efforts to reduce the cost and risk of dementia and outlines a series of recommended action steps.

Four Leading Alzheimer’s Organizations Agree on Need For National, Time-Based Prevention Goal

Director of the National Center for Chronic Disease Prevention and Health Promotion, Senior Director of Center for the Future of Aging, and Leading U.S. Alzheimer’s Researcher Resoundingly Support UsAgainstAlzheimer’s Call for a Time-based Alzheimer’s Prevention Goal

UsAgainstAlzheimer’s Applauds Positive News on Alzheimer’s Drug Aducanumab

Statement from George Vradenburg on the announcement by Biogen and Eisai of plans to seek regulatory approval in early 2020 by the Food and Drug Administration (FDA) for aducanumab, an investigational treatment for early Alzheimer’s disease.

New Study Highlights Need for Healthcare Providers to Engage Alzheimer’s Caregivers

A new study from UsAgainstAlzheimer's and Mayo Clinic spotlights the often-overlooked need for family caregivers of people with Alzheimer’s disease to be more engaged by physicians during medical appointments with their loved ones.

New Biomarkers Repository

More research and cautious optimism

Reducing Cost and Risk

National Prevention Goal

Aducanumab Reversal

Engaging Family Caregivers

  • A Letter from Our Chairman

    UsAgainstAlzheimer’s Brain Health Partnership has issued a Call to Action white paper outlining recommendations for building a better system of care to promote brain health and fight back against Alzheimer’s.

Read the Letter

We Are Committed to Stopping Alzheimer's by 2020.

  • Blog Post
    Thumbnail

    A road map for including Latinos and African Americans in Alzheimer’s research

    *This piece originally appeared in STAT News.

    Alzheimer’s disease is the only leading cause of death in the U.S. that is still on the rise and that does

    Read more
  • Blog Post
    Thumbnail

    U.S. surgeons general: Dementia is our top public health crisis | Commentary

    *This piece originally appeared in the Orlando Sentinal

    Over the span of more than 20 years and three presidents, as surgeons general we’ve confronted more than our fair share

    Read more
  • Alzheimer’s impact is a societal and economic issue, health advocate says

    *This article originally appeared on Cleveland.com 

    CLEVELAND, Ohio -- Alzheimer’s disease afflicts nearly 6 million people in the United States, and sadly affects the many more millions of people

    Read more

The Pulse of the Community: Volume 4, Fall 2019

The A-LIST transforms the stories of more than 8,000 people living with Alzheimer’s or other dementias into evidence-based insights by providing unique, rapid-response, self-reported data through virtual surveys on what matters most on a wide range of Alzheimer’s-related topics. The A-LIST offers a powerful and validating voice for those living with Alzheimer’s and those caring for them, and a pathway to help expand treatments and accelerate toward a cure.